loadpatents
name:-0.057681083679199
name:-0.024138927459717
name:-0.0014519691467285
Lee; Francis Y. Patent Filings

Lee; Francis Y.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lee; Francis Y..The latest application filed is for "novel tricyclic compounds as anticancer agents".

Company Profile
0.21.48
  • Lee; Francis Y. - Yardley PA
  • Lee; Francis Y - Yardley PA
  • Lee; Francis Y. - Princeton NJ
  • Lee, Francis Y. - Fort Lee NJ
  • Lee; Francis Y. - Shatin HK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Tricyclic compounds as anticancer agents
Grant 10,112,941 - Norris , et al. October 30, 2
2018-10-30
Novel Tricyclic Compounds As Anticancer Agents
App 20170327498 - Norris; Derek J. ;   et al.
2017-11-16
Antibody-drug Conjugate Of An Anti-glypican-3 Antibody And A Tubulysin Analog, Preparation And Uses
App 20170326249 - PAN; Chin ;   et al.
2017-11-16
Tricyclic compounds as anticancer agents
Grant 9,751,879 - Norris , et al. September 5, 2
2017-09-05
Combination therapy for the treatment of proliferative diseases
Grant 9,492,469 - Lee November 15, 2
2016-11-15
Novel Tricyclic Compounds As Anticancer Agents
App 20160326173 - Norris; Derek J. ;   et al.
2016-11-10
Tricyclic Compounds As Anticancer Agents
App 20160318928 - Norris; Derek J. ;   et al.
2016-11-03
Tricyclic compounds as anticancer agents
Grant 9,458,156 - Norris , et al. October 4, 2
2016-10-04
Novel Tricyclic Compounds As Anticancer Agents
App 20160176864 - Norris; Derek J. ;   et al.
2016-06-23
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
Grant 9,273,014 - Gavai , et al. March 1, 2
2016-03-01
Combination Therapy For The Treatment Of Proliferative Diseases
App 20160022723 - Lee; Francis Y.
2016-01-28
Bis(fluoroalkyl)-1,4-benzodiazepinone Compounds And Prodrugs Thereof
App 20150166489 - Gavai; Ashvinikumar V. ;   et al.
2015-06-18
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
Grant 8,999,918 - Gavai , et al. April 7, 2
2015-04-07
Combination Of Anti-ctla4 Antibody With Diverse Therapeutic Regimens For The Synergistic Treatment Of Proliferative Diseases
App 20140141024 - Jure-Kunkel; Maria ;   et al.
2014-05-22
Use of Epothilone D in Treating Tau-Associated Diseases Including Alzheimer's Disease
App 20140135367 - Albright; Charles F. ;   et al.
2014-05-15
Bisfluoroalkyl-1,4-benzodiazepinone Compounds
App 20140100365 - Gavai; Ashvinikumar V. ;   et al.
2014-04-10
Bis(fluoroalkyl)-1,4-benzodiazepinone Compounds And Prodrugs Thereof
App 20140087992 - Gavai; Ashvinikumar V. ;   et al.
2014-03-27
Use of epothilone D in treating Tau-associated diseases including Alzheimer's disease
Grant 8,673,949 - Albright , et al. March 18, 2
2014-03-18
Bisfluoroalkyl-1,4-benzodiazepinone compounds
Grant 8,629,136 - Gavai , et al. January 14, 2
2014-01-14
Combination Of Anti-ctla4 Antibody With Diverse Therapeutic Regimens For The Synergistic Treatment Of Proliferative Diseases
App 20130142805 - Jure-Kunkel; Maria ;   et al.
2013-06-06
Biomarker Identifying the Reactivation of STAT3 After Src Inhibition
App 20130012519 - Johnson; Faye M. ;   et al.
2013-01-10
Bisfluoroalkyl-1,4-benzodiazepinone Compounds
App 20120245151 - GAVAI; ASHVINIKUMAR V. ;   et al.
2012-09-27
Methods of identifying and treating individuals exhibiting mutant kit protein
Grant 8,247,419 - Lee , et al. August 21, 2
2012-08-21
Combination Of Anti-ctla4 Antibody With Dasatinib For The Treatment Of Proliferative Diseases
App 20120135001 - Jure-Kunkel; Maria ;   et al.
2012-05-31
Combination Of Anti-ctla4 Antibody With Diverse Therapeutic Regimens For The Synergistic Treatment Of Proliferative Diseases
App 20120121604 - Jure-Kunkel; Maria ;   et al.
2012-05-17
Combination of anti-CTLA4 antibody with dasatinib for the treatment of proliferative diseases
Grant 8,119,129 - Jure-Kunkel , et al. February 21, 2
2012-02-21
Use of Epothilone D in Treating Tau-Associated Diseases Including Alzheimer's Disease
App 20110230528 - Albright; Charles F. ;   et al.
2011-09-22
Methods For Treating Cancer In Patients Having Breast Cancer Resistance Protein Overexpression
App 20110112155 - Lee; Francis Y ;   et al.
2011-05-12
Aziridinyl-epothilone compounds
Grant 7,872,145 - Vite , et al. January 18, 2
2011-01-18
Method of treating chronic myelogenous leukemia cells
Grant 7,799,788 - Bhalla , et al. September 21, 2
2010-09-21
Biomaker Identifying The Reactivation Of Stat3 After Src Inhibition
App 20100173426 - Johnson; Faye M. ;   et al.
2010-07-08
Combination of anti-CTLA4 antibody with dasatinib for the treatment of proliferative diseases
App 20100098701 - Jure-Kunkel; Maria ;   et al.
2010-04-22
T315a And F317i Mutations Of Bcr-abl Kinase Domain
App 20100029676 - Sawyers; Charles L. ;   et al.
2010-02-04
Methods Of Identifying And Treating Individuals Exhibiting Mutant Bcr/Abl Kinase Polypeptides
App 20090306094 - Lee; Francis Y. ;   et al.
2009-12-10
Combination of Src kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
Grant 7,622,472 - Lee November 24, 2
2009-11-24
Use Of Epothilone D In Treating Tau-associated Diseases Including Alzheimer's Disease
App 20090270465 - Albright; Charles F. ;   et al.
2009-10-29
Methods for Modulating Tumor Growth and Metastasis
App 20090258937 - Lee; Francis Y. ;   et al.
2009-10-15
Methods of identifying and treating individuals exhibiting mutant kit protein
App 20090221601 - Lee; Francis Y. ;   et al.
2009-09-03
Method Of Treating Chronic Myelogenous Leukemia Cells
App 20090215792 - Bhalla; Kapil N. ;   et al.
2009-08-27
Methods of Identifying and Treating Individuals Exhibiting Complex Karyotypes
App 20090197893 - Lee; Francis Y. ;   et al.
2009-08-06
Methods of Identifying and Treating Individuals Exhibiting Mutant SRC Kinase Polypeptides
App 20090163510 - Lee; Francis Y.
2009-06-25
Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
Grant 7,537,891 - Huang , et al. May 26, 2
2009-05-26
Methods of Identifying and Treating Individuals Exhibiting MDR-1 Overexpression With Protein Tyrosine Kinase Inhibitors and Combinations Thereof
App 20090099197 - Lee; Francis Y.
2009-04-16
Combination Of A Src Kinase Inhibitor And A Bcr-abl Inhibitor For The Treatment Of Proliferative Diseases
App 20090093495 - Lee; Francis Y.
2009-04-09
Methods of using EPHA2 for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
Grant 7,504,211 - Huang , et al. March 17, 2
2009-03-17
Combinations, Methods And Compositions For Treating Cancer
App 20090054415 - Lee; Francis Y. ;   et al.
2009-02-26
Combination Of Src Kinase Inhibitors And Chemotherapeutic Agents For The Treatment Of Proliferative Diseases
App 20080153842 - Lee; Francis Y.
2008-06-26
Conjugates Of Aziridinyl-epothilone Analogs And Pharmaceutical Compositions Comprising Same
App 20070275904 - Vite; Gregory D. ;   et al.
2007-11-29
Aziridinyl-epothilone Compounds
App 20070276018 - Vite; Gregory D. ;   et al.
2007-11-29
Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
Grant 7,265,260 - Bol , et al. September 4, 2
2007-09-04
Identification of polynucleotides and polypeptide for predicting activity of compounds that interact with protein tyrosine kinases and/or protein tyrosine kinase pathways
App 20070166704 - Huang; Fei ;   et al.
2007-07-19
Use of dasatinib for the treatment of bone metastasis
App 20070093499 - Lee; Francis Y. ;   et al.
2007-04-26
Combinations, methods and compositions for treating cancer
App 20060235006 - Lee; Francis Y. ;   et al.
2006-10-19
Methods for modulating tumor growth and metastasis
App 20060194770 - Lee; Francis Y. ;   et al.
2006-08-31
Combination of a SRC kinase inhibitor and a BCR-ABL inhibitor for the treatment of proliferative diseases
App 20060094728 - Lee; Francis Y.
2006-05-04
Methods for modulating tumor growth and metastasis
Grant 7,037,906 - Lee May 2, 2
2006-05-02
Prodrugs of protein tyrosine kinase inhibitors
App 20060069101 - Kim; Kyoung S. ;   et al.
2006-03-30
Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
App 20060029944 - Huang; Fei ;   et al.
2006-02-09
Combination of SRC Kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
App 20050009891 - Lee, Francis Y.
2005-01-13
Novel bone graft composite
App 20050010305 - Lee, Francis Y.
2005-01-13
Synergistic methods and compositions for treating cancer
App 20040209930 - Carboni, Joan M. ;   et al.
2004-10-21
Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
App 20040106132 - Huang, Fei ;   et al.
2004-06-03
Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
App 20030182668 - Bol, David K. ;   et al.
2003-09-25
Synergistic methods and compositions for treating cancer
Grant 6,537,988 - Lee March 25, 2
2003-03-25
Synergistic methods and compositions for treating cancer
App 20020002162 - Lee, Francis Y.
2002-01-03
Combined digital clock and thermometer with integral stand
Grant D289,380 - Lee April 21, 1
1987-04-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed